# Soonr Health Officially Launches in the U.S. with Connected At-Home Fertility Tracking for Couples

- Link: https://www.thailand-business-news.com/pr-news/soonr-health-officially-launches-in-the-u-s-with-connected-at-home-fertility-tracking-for-couples
- Published: 2026-06-04T20:00:00+07:00
- Author: PR Newswire

_With the launch of Surearly SMART on Amazon, Soonr Health now offers couples connected
at-home ovulation and hormone testing, the first device in an expanding ecosystem
built around dyadic health._

SEOUL, South Korea, June 4, 2026 /PRNewswire/ — Vespexx Inc., a femtech company 
building products around the science of dyadic health, today announced the official
U.S. launch of **Soonr Health**, a preconception health platform designed for couples
who are trying to conceive. The launch coincides with the U.S. debut of **Surearly
SMART** on Amazon, a connected at-home hormone testing device that integrates directly
into the Soonr Health experience. Following an early access release in February,
Soonr Health’s complete platform is now open to U.S. couples, with both partners
using the app on their own phones to log their symptoms and habits, and to share
cycle, ovulation tracking and hormone test results from the integrated device.

 [ ⌊Soonr Health, Vespexx's preconception platform, connects with the Surearly SMART hormone testing device so couples can track fertility and daily habits together.⌉ ](https://mma.prnasia.com/media2/2987404/PRImage_final.html)

Soonr Health, Vespexx’s preconception platform, connects with the Surearly SMART
hormone testing device so couples can track fertility and daily habits together.

According to the American Society for Reproductive Medicine, male factors are the
sole cause of infertility in approximately 20% of cases and contribute to another
30 to 40%, with the World Health Organization placing overall male factor involvement
at roughly half. Yet most consumer fertility tools focus exclusively on one partner’s
data. Soonr is built around **dyadic health**, a category Vespexx has been advancing
in recognition that conception, pregnancy outcomes, and long-term family health 
are shaped by both partners’ biology and behavior.

**From Signaling to Soonr Health**

Soonr builds on Vespexx’s flagship app **Signaling**, which has pioneered couple-
based period tracking since 2023 and now serves more than 800,000 users across Asia
and beyond. As Vespexx prepared to enter the U.S. market, the team identified preconception
as the moment when dyadic health matters most, when a couple’s biology, behavior,
and daily decisions most directly shape an outcome they share. Soonr is purpose-
built for that moment.

"Most fertility products were designed for a woman to use alone, often with the 
quiet assumption that her partner would cheer her on from the sidelines," said **
Scarlett Joowon Jung, CEO of Vespexx**. "We’ve spent the last three years proving
with Signaling that couples want to share this experience, and Soonr brings that
conviction into the moment that matters most. The science backs it up, and the experience
of trying to conceive deserves to reflect that."

**Built as a behavioral platform, not just a tracker**

Beyond cycle and hormone tracking, Soonr is structured as a behavioral platform 
that both partners actively use. Habit, symptom, meal, and exercise logging gives
each partner a way to contribute to their shared fertility picture, alongside a 
gamified visualization that grows as the couple’s data accumulates. The result is
a preconception experience that reflects how couples actually live, with both people
engaged in the same daily rhythm.

**A platform designed to grow with the science**

Soonr connects with at-home testing so couples can bring real biological signals
into their daily routine. The first integrated device is **Surearly SMART**, an 
at-home hormone testing device that reads ovulation and key reproductive hormone
markers. Test results flow into Soonr, where both partners can view and track them
together.

Surearly SMART is manufactured by **Sugentech (KOSDAQ: 253840)**, Vespexx’s parent
company and a publicly listed Korean biotech with 15 years of in-vitro diagnostic
expertise spanning ovulation, pregnancy, and clinical testing.

Additional device integrations are planned across the preconception spectrum, including
male reproductive health testing, as Soonr expands its platform.

**Availability**

Soonr Health is available now as a free download in the U.S. on iOS and Android.
Premium features are available at **$12.99 per month** or, as a limited-time launch
offer, **$65.99 per year**. The **Surearly SMART Starter Kit (Test Reader and Test
Sticks)** is available now on Amazon at a limited-time launch price of **$119**,
reduced from the regular price of **$169**.

For more on Soonr Health and the dyadic health framework, visit [https://soonr.health/](https://soonr.health/).

**About Soonr Health**

Soonr Health is a preconception platform for couples, built on the principle of 
dyadic health: that fertility, pregnancy, and family health are shaped by both partners.
The app combines cycle and ovulation tracking, habit and symptom logging, partner-
aware sharing, and integrated at-home hormone testing. Soonr Health is developed
by Vespexx Inc.

**About Vespexx**

Vespexx Inc. is a femtech company headquartered in Seoul, building dyadic health
products for couples globally. Vespexx’s flagship app Signaling, which pioneered
couple-based period tracking, has served more than 800,000 users across Asia and
beyond since 2023. Vespexx is a subsidiary of Sugentech (KOSDAQ: 253840), a publicly
listed Korean biotech specializing in in-vitro diagnostics.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Soonr Health Officially Launches in the U.S. with Connected At-Home Fertility Tracking for Couples ](http://www.prnasia.com/story/archive/4967425_CN67425_0?rand=184833)
